NTMir Board Chair Annnouncement
Mark your calendars!
Tuesday December 1st
European Union approves Arikayce
inhaled liposomal amikacin
Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivoREAD MORE
We Launched a Companion Website for Bronchiectasis
Coronavirus Information and Resources
"INSIGHT" A Patients Perspective
Insight into the lung disease caused by nontuberculous
mycobacteria (NTM), and empowers the patient to participate in his or her own
AVAILABLE IN VARIOUS LANGUAGES, REQUEST YOUR COPY TODAY.
A Physician’s Perspective
by Ed Chan, MD
Airway clearance therapy is an integral part of daily lung care and respiratory hygiene
Click here to sign up for the latest news on NTMir
SIGN UP NOW
WHO WE ARE
NTMir advances a broad agenda on behalf of people with nontuberculous mycobacterial (NTM) disease, as well as healthcare providers, researchers….